Tower Research Capital LLC (Trc) Harrow Health, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Harrow Health, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 190 shares of HROW stock, worth $8,151. This represents 0.0% of its overall portfolio holdings.

Number of Shares

190

Previous 5,284 96.4%

Holding current value

$8,151

Previous $110,000 92.73%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$20.85 - $46.47 $106,209 - $236,718	-5,094 Reduced 96.4%	190 $8,000
Q2 2024 Aug 13, 2024	BUY	$10.0 - $21.64 $51,140 - $110,666	5,114 Added 3008.24%	5,284 $110,000
Q1 2024 May 15, 2024	SELL	$9.3 - $13.23 $73,497 - $104,556	-7,903 Reduced 97.89%	170 $2,000
Q4 2023 Feb 13, 2024	BUY	$8.1 - $16.36 $35,964 - $72,638	4,440 Added 122.21%	8,073 $90,000
Q3 2023 Nov 14, 2023	SELL	$14.03 - $22.08 $133,635 - $210,311	-9,525 Reduced 72.39%	3,633 $52,000
Q2 2023 Aug 14, 2023	BUY	$17.37 - $28.08 $195,134 - $315,450	11,234 Added 583.89%	13,158 $250,000
Q1 2023 May 09, 2023	SELL	$13.84 - $21.46 $51,484 - $79,831	-3,720 Reduced 65.91%	1,924 $41,000
Q4 2022 Feb 10, 2023	BUY	$10.28 - $14.78 $29,688 - $42,684	2,888 Added 104.79%	5,644 $83,000
Q3 2022 Nov 10, 2022	BUY	$6.57 - $24.88 $15,235 - $57,696	2,319 Added 530.66%	2,756 $33,000
Q2 2022 Aug 15, 2022	SELL	$5.75 - $7.74 $26,973 - $36,308	-4,691 Reduced 91.48%	437 $3,000
Q1 2022 May 12, 2022	BUY	$6.77 - $8.66 $4,007 - $5,126	592 Added 13.05%	5,128 $35,000
Q4 2021 Feb 14, 2022	BUY	$8.5 - $12.0 $35,776 - $50,508	4,209 Added 1287.16%	4,536 $39,000
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $16,880 - $25,599	-2,415 Reduced 88.07%	327 $3,000
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $1,369 - $2,269	205 Added 8.08%	2,742 $26,000
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $21,753 - $38,329	-3,475 Reduced 57.8%	2,537 $17,000
Q4 2020 Feb 16, 2021	SELL	$4.76 - $6.93 $73,175 - $106,534	-15,373 Reduced 71.89%	6,012 $41,000
Q3 2020 Nov 16, 2020	BUY	$4.71 - $7.36 $95,514 - $149,253	20,279 Added 1833.54%	21,385 $120,000
Q2 2020 Aug 13, 2020	SELL	$3.61 - $6.47 $3,841 - $6,884	-1,064 Reduced 49.03%	1,106 $6,000
Q1 2020 May 15, 2020	SELL	$3.5 - $7.31 $20,944 - $43,743	-5,984 Reduced 73.39%	2,170 $8,000
Q4 2019 Feb 07, 2020	BUY	$4.6 - $7.88 $24,278 - $41,590	5,278 Added 183.52%	8,154 $64,000
Q3 2019 Nov 05, 2019	BUY	$4.89 - $8.0 $10,880 - $17,800	2,225 Added 341.78%	2,876 $16,000
Q2 2019 Aug 13, 2019	BUY	$4.2 - $8.7 $1,894 - $3,923	451 Added 225.5%	651 $6,000
Q1 2019 May 14, 2019	BUY	$4.75 - $7.1 $950 - $1,420	200 New	200 $1,000

Others Institutions Holding HROW

# of Institutions

177

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.16B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Harrow Health, Inc. Transaction History